Rhumbline Advisers Santen Pharmaceutical CO Unspo Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Santen Pharmaceutical CO Unspo stock. As of the latest transaction made, Rhumbline Advisers holds 30 shares of SNPHY stock, worth $327. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30
Previous 30 -0.0%
Holding current value
$327
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023
BUY
$7.85 - $9.57 $235 - $287
30 New
30 $0

Others Institutions Holding SNPHY

# of Institutions
3
Shares Held
132
Call Options Held
0
Put Options Held
0
View Full List

About SANTEN PHARMACEUTICAL CO UNSPO

SNPHY Quotes by TradingView
  • Ticker SNPHY
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 387,904,992
  • Market Cap $4.24B
More about SNPHY
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email